Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8647353 | Multiple Sclerosis and Related Disorders | 2018 | 9 Pages |
Abstract
We report the case of a patient who died from the rare complication of Listeriosis in the immediate phase following alemtuzumab administration one month after discontinuing dimethyl fumarate (DMF). There is considerable overlap with typical post-infusion symptoms therefore high surveillance and low threshold for empirical or possible prophylactic antibiotic therapy is advocated.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
L.J.W. Canham, A. Manara, J. Fawcett, M. Rolinski, A. Mortimer, K.E.A. Inglis, D.A. Cottrell,